ROBYN LANASA: Open Payments
NPI 1093344244 · CHESTER, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 29 payments from 15 companies in 2025. Trend: 2023 $1,085 · 2024 $1,221 · 2025 $1,476
Food & beverage: $779Travel & lodging: $697
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $697 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $160 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $142 |
| W. L. Gore & Associates, Inc. | 1 | $112 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| Amgen Inc. | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| CVRx, Inc. | 1 | $29 |
| Lilly USA, LLC | 1 | $22 |
Products named: SYMPLICITY G3, Kerendia, LifeVest, GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis, LEQVIO, REPATHA, JARDIANCE, VERQUVO.
Industry payments across MD — which companies pay providers there.
